Teva Beats Nestle Unit's Suit Over Rosacea Cream Patents
Teva Pharmaceutical Industries Ltd. didn't infringe a trio of patents related to an anti-rosacea cream produced by Nestle's skin care unit because the patents covered a previously disclosed treatment, a Delaware...To view the full article, register now.
Already a subscriber? Click here to view full article